Literature DB >> 16442531

Repression of SOX6 transcriptional activity by SUMO modification.

R Fernández-Lloris1, N Osses, E Jaffray, L N Shen, O A Vaughan, D Girwood, R Bartrons, J L Rosa, R T Hay, F Ventura.   

Abstract

SOX6 plays key functions in several developmental processes, including neurogenesis and skeleton formation. In this report, we show that SOX6 is modified in vitro and in vivo by small ubiquitin-related modifier (SUMO) on two distinct sites. Mutation of both sites abolished SOX6 sumoylation and increased SOX6 transcriptional activity. SUMO dependent repression of SOX6 transcription was promoted by UBC9 whereas siRNA to UBC9, cotransfection of inactive UBC9 or a SUMO protease increased SOX6 transcriptional activity. Furthermore, co-expression of SOX6 with SUMO2 results in the appearance of SOX6 in a punctate nuclear pattern that colocalized with promyelocytic leukemia protein, which was partially abolished by mutations in SOX6 sumoylation sites.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16442531     DOI: 10.1016/j.febslet.2006.01.031

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  12 in total

1.  Five friends of methylated chromatin target of protein-arginine-methyltransferase[prmt]-1 (chtop), a complex linking arginine methylation to desumoylation.

Authors:  Pavlos Fanis; Nynke Gillemans; Ali Aghajanirefah; Farzin Pourfarzad; Jeroen Demmers; Fatemehsadat Esteghamat; Ratna K Vadlamudi; Frank Grosveld; Sjaak Philipsen; Thamar B van Dijk
Journal:  Mol Cell Proteomics       Date:  2012-08-07       Impact factor: 5.911

Review 2.  Walk the Line: The Role of Ubiquitin in Regulating Transcription in Myocytes.

Authors:  Vidyani Suryadevara; Monte S Willis
Journal:  Physiology (Bethesda)       Date:  2019-09-01

3.  Differential effects of sumoylation on transcription and alternative splicing by transcription elongation regulator 1 (TCERG1).

Authors:  Miguel Sánchez-Álvarez; Marta Montes; Noemí Sánchez-Hernández; Cristina Hernández-Munain; Carlos Suñé
Journal:  J Biol Chem       Date:  2010-03-09       Impact factor: 5.157

4.  Analysis of oxygen/glucose-deprivation-induced changes in SUMO3 conjugation using SILAC-based quantitative proteomics.

Authors:  Wei Yang; J Will Thompson; Zhengfeng Wang; Liangli Wang; Huaxin Sheng; Matthew W Foster; M Arthur Moseley; Wulf Paschen
Journal:  J Proteome Res       Date:  2011-12-01       Impact factor: 4.466

5.  Cyclin-Dependent Kinase-Dependent Phosphorylation of Sox2 at Serine 39 Regulates Neurogenesis.

Authors:  Shuhui Lim; Akshay Bhinge; Sara Bragado Alonso; Irene Aksoy; Julieta Aprea; Chit Fang Cheok; Federico Calegari; Lawrence W Stanton; Philipp Kaldis
Journal:  Mol Cell Biol       Date:  2017-07-28       Impact factor: 4.272

Review 6.  Control of cell fate and differentiation by Sry-related high-mobility-group box (Sox) transcription factors.

Authors:  Véronique Lefebvre; Bogdan Dumitriu; Alfredo Penzo-Méndez; Yu Han; Bhattaram Pallavi
Journal:  Int J Biochem Cell Biol       Date:  2007-06-06       Impact factor: 5.085

7.  Sumoylation regulates interaction of FOG1 with C-terminal-binding protein (CTBP).

Authors:  Jonathan W Snow; Jonghwan Kim; Caroline R Currie; Jian Xu; Stuart H Orkin
Journal:  J Biol Chem       Date:  2010-06-28       Impact factor: 5.157

Review 8.  Enzymatic Machinery of Ubiquitin and Ubiquitin-Like Modification Systems in Chondrocyte Homeostasis and Osteoarthritis.

Authors:  Ye Liu; Vladimir Molchanov; Tao Yang
Journal:  Curr Rheumatol Rep       Date:  2021-07-03       Impact factor: 4.592

Review 9.  The role of Sox genes in lung morphogenesis and cancer.

Authors:  Yongzhao Zhu; Yong Li; Jun Wei Jun Wei; Xiaoming Liu
Journal:  Int J Mol Sci       Date:  2012-11-26       Impact factor: 5.923

10.  Trip12, a HECT domain E3 ubiquitin ligase, targets Sox6 for proteasomal degradation and affects fiber type-specific gene expression in muscle cells.

Authors:  Chung-Il An; Edward Ganio; Nobuko Hagiwara
Journal:  Skelet Muscle       Date:  2013-05-10       Impact factor: 4.912

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.